Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy

Kidney International

Volumn 82, Issue 7, 2012, Pages 797-804

  Hoxha, Elion ^a   Kneiler, Ursula ^a   Stege, Gesa ^a   Zahner, Gunther ^a   Thiele, Ina ^a   Panzer, Ulf ^a   Harendza, Sigrid ^a   Helmchen, Udo M ^a   Stahl, Rolf A K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

phospholipase A2 receptor; phospholipase A2 receptor antibodies; primary and secondary membranous nephropathy

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; M TYPE PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOLIPASE A2 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

EID: 84866422732     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.209     Document Type: Article

References (19)

1. Couser WG, Steinmuller DR, Stilmant MM et al. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 1978; 62: 1275-1287.
2. Kerjaschki D, Miettinen A, Farquhar MG. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane. J Exp Med 1987; 166: 109-128.
3. Ronco P, Debiec H. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. J Am Soc Nephrol 2010; 21: 564-569.
4. Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis 1993; 22: 5-10.
5. Beck LH. Membranous nephropathy and malignancy. Semin Nephrol 2010; 30: 635-644.
6. Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol 2005; 16: 1188-1194.
7. Beck LH, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.
8. Hofstra JM, Beck LH, Beck DM et al. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6: 1286-1291.
9. Hoxha E, Harendza S, Zahner G et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011; 26: 2526-2532.
10. Beck LH, Fervenza FC, Beck DM et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1543-1550.
11. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690.
12. Makker SP, Widstrom R, Huang J. Transcription and translation of gp600 and receptor-associated protein (RAP) in active Heymann nephritis. Am J Pathol 1995; 146: 1481-1487.
13. Knehtl M, Debiec H, Kamgang P et al. A case of phospholipase A2 receptor-positive membranous nephropathy preceding sarcoidassociated granulomatous tubulointerstitial nephritis. Am J Kidney Dis 2011; 57: 140-143.
14. Qin W, Beck Jr LH, Zeng C et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1137-1143.
15. Doi T, Mayumi M, Kanatsu K et al. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 1984; 58: 57-62.
16. Noel L-H, Aucouturier P, Monterio RC et al. Glomerular and serum immunoglobin G subclasses in membranous nephropathy and antiglomerular basement membrane nephritis. Clin Immunol Immunopathol 1988; 46: 186-194.
17. Imai H, Hamai K, Komatsuda A et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 1997; 51: 270-276.
18. Ohtani H, Wakui H, Okuyama S et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 2004; 19: 574-579.
19. Stahl RA, Hoxha E, Fechner K. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med 2010; 363: 496-498.